#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Frostbite Measles Lupus nephritis Primary immunodeficiency syndrome Subdural haematoma Monogenic diabetes Antiphospholipid syndrome Astrocytoma Myasthenia gravis Neuronal ceroid lipofuscinosis Chordoma Blood iron increased Endometrial cancer recurrent Cortical dysplasia Antithrombin III deficiency More trials…

    Learn about Rare Diseases

    Brain stem glioma – Basic Information Andersen-Tawil syndrome – Diagnostics Encephalitis autoimmune Ornithine transcarbamoylase deficiency – Trials in Disease Anaplastic thyroid cancer Proteus syndrome – Treatment Hairy cell leukaemia recurrent – Basic Information Focal segmental glomerulosclerosis – Trials in Disease Haemophilia A with anti factor VIII – Life with Disease Angelman’s syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tisagenlecleucel Indometacin Fosphenytoin Sodium GSKVX000000034792 Ioflupane (123I) Saxagliptin Elafibranor Tiragolumab Pozelimab Nms-03305293 ADMILPARANT Ceralasertib M1P Dipotassium Salt INSULIN DETEMIR Omp10 Nicotinamide Mecasermin Rinfabate Mianserin Hydrochloride Concizumab Iptacopan Hydrochloride More therapies…

    Learn about Your Condition

    Corneal dystrophy Body mass index increased Endocarditis enterococcal Dent's disease Escherichia infection Caesarean section Angiosarcoma recurrent Polycythaemia vera Cardiomyopathy Neuroblastoma Ovarian cancer recurrent Albright's disease Ischaemic skin ulcer Retinal neovascularisation Plasma cell myeloma refractory More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Rheumatoid arthritis

  • Study of CIT-013 at Three Different Doses for Patients with Moderately Active Rheumatoid Arthritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Sodium Chloride
    Belgium Germany The Netherlands Poland Spain

  • Study on the Effects of Filgotinib on Heart Health in Patients with Rheumatoid Arthritis Without Cardiovascular Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Filgotinib
    The Netherlands

  • Study on the Effects of IMVT-1402 for Adults with Difficult-to-Treat Rheumatoid Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • IMEROPRUBART
    Bulgaria Czechia Germany Hungary Poland Romania +1

  • Study of Tocilizumab Subcutaneous Injection to Evaluate Bone Healing in Adult Patients with Rheumatoid Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Tocilizumab
    France

  • Study on the Effectiveness and Safety of CT-P13 for Patients with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Folic Acid
    • Ibuprofen
    • HYDROXYCHLOROQUINE
    Poland

  • Study on Spironolactone for Treating Active Rheumatoid Arthritis in Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Spironolactone
    France Germany
Previous Page
1 … 7 8 9 10 11 12
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!